9.75Open9.75Pre Close0 Volume1 Open Interest118.00Strike Price0.00Turnover182.45%IV54.96%PremiumAug 30, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry9.75Extrinsic Value100Contract SizeAmericanOptions Type0.0469Delta0.0059Gamma274.80Leverage Ratio-0.1588Theta0.0004Rho12.90Eff Leverage0.0089Vega
Fomo Mofo : we all saw the webinar. for a company with 18 employees id say they are doing really well. let's hope the stock gods smile upon us on Monday with some official good news
Ken Griffin Charity2 : Why not provide the source? GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox This press release was published 19 December 2023.
Geovax has been working on a covid vaccine for the past 4 years. There is still no approved covid vaccine, much less one for mpox.